prikaz prve stranice dokumenta Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control
  Preuzmi
PDF 330.52 KB
Znanstveni rad - Izvorni znanstveni rad
Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control
Acta clinica Croatica, 59 (2020), 4; 641-648. https://doi.org/10.20471/acc.2020.59.04.10
Pintarić, Hrvoje; Knezović Florijan, Marijana; Bridges, Ian; Steiner, Robert; Zaputović, Luka; Miličić, Davor

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Pintarić, H., Knezović Florijan, M., Bridges, I., Steiner, R., Zaputović, L. i Miličić, D. (2020). Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control. Acta clinica Croatica, 59. (4), 641-648. doi: 10.20471/acc.2020.59.04.10

Pintarić, Hrvoje, et al. "Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control." Acta clinica Croatica, vol. 59, br. 4, 2020, str. 641-648. https://doi.org/10.20471/acc.2020.59.04.10

Pintarić, Hrvoje, Marijana Knezović Florijan, Ian Bridges, Robert Steiner, Luka Zaputović i Davor Miličić. "Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control." Acta clinica Croatica 59, br. 4 (2020): 641-648. https://doi.org/10.20471/acc.2020.59.04.10

Pintarić, H., et al. (2020) 'Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control', Acta clinica Croatica, 59(4), str. 641-648. doi: 10.20471/acc.2020.59.04.10

Pintarić H, Knezović Florijan M, Bridges I, Steiner R, Zaputović L, Miličić D. Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control. Acta clinica Croatica [Internet]. 2020. [pristupljeno 28.12.2024.];59(4):641-648. doi: 10.20471/acc.2020.59.04.10

H. Pintarić, M. Knezović Florijan, I. Bridges, R. Steiner, L. Zaputović i D. Miličić, "Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control", Acta clinica Croatica, vol. 59, br. 4, str. 641-648, 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:956509. [Citirano: 28.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:956509
Podaci o radu
Naslov (engleski)Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an Observational Study of Treatment Patterns and Lipid Control
AutorHrvoje Pintarić
MBZ: 224771
AutorMarijana Knezović Florijan
AutorIan Bridges
AutorRobert Steiner
MBZ: 167711
AutorLuka Zaputović
AutorDavor Miličić
MBZ: 31460
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Our observational study evaluated current management of elevated low-density lipoprotein cholesterol (LDL-C) in adult secondary prevention patients (all very high risk (VHR) by European guidelines) attending specialist clinics across Croatia. Data were collected retrospectively from patient records for the preceding 12 months. The subset judged to be at extreme risk (ER ; American Association of Clinical Endocrinologists (AACE) criteria ; n=48) were compared with the remaining patients (VHR group ; n=41). All patients were receiving statins (75.6% VHR/81.3% ER at high-intensity), with only a minority receiving concomitant lipid-lowering treatment (7.3% VHR/16.7% ER). Median (Q1, Q3) LDL-C levels at the last visit were 1.9 (1.6, 2.4) mmol/L for VHR and 2.1 (1.5, 3.1) mmol/L for ER, with only 41.5% (95% CI 26.3-57.9) of VHR patients and 27.1% (15.3- 41.9) of ER patients attaining their LDL-C targets (<1.8 mmol/L and <1.42 mmol/L, respectively). Thus, we found that a substantial proportion of VHR and ER secondary prevention patients being treated across Croatia had LDL-C levels exceeding the targets recommended in the European and newer AACE guidelines, but not all were receiving high- intensity statins. Identification of ER patients and their lipid patterns may help optimize usage of high-intensity statin treatment, alone or along with newer treatments, for better control of elevated LDL -C.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - domaća recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaActa clinica Croatica
Brojčani podacivol. 59, br. 4, str. 641-648
p-ISSN0353-9466
DOIhttps://doi.org/10.20471/acc.2020.59.04.10
URN:NBNurn:nbn:hr:184:956509
Datum objave publikacije2020
URL dokumentahttp://bib.irb.hr/1144446
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-02-24 13:16:11